About

Ai1Y partners with organizations to design, activate, and scale accessibility as a business practice. Our work spans digital, physical, and operational experiences—supporting teams where accessibility intersects with technology, customer experience, and organizational change.

About Ai1Y

We partner with enterprises to advise, lead, and implement digital accessibility across the company digital ecosystem.

Disability inclusion, patient centricity and the digital determinants of health: in the age of the digital patient, equitable access to digital content significantly impacts health outcomes.

We operate at the intersection of technology, compliance, and enterprise transformation — helping life sciences and regulated industry organizations build accessible digital experiences at scale.

  • Fractional Chief Accessibility Officer (CAO) leadership for organizations that need senior‑level accessibility expertise without a full‑time hire
  • Accessibility audits and testing resources, including policy, design, content, and platform assessments
  • Point‑of‑view (POV) guidance on platform and vendor assessments, helping teams make informed, future‑proof decisions
  • Scalable playbooks and operating models that align accessibility to roles, workflows, and maturity levels across the organization

Our Leadership Team

Portrait of Stephen Framil, PhD

Stephen Framil, PhD

Chief Executive Officer

Stephen Framil is the CEO of Ai1y Inc. and the Former Corporate Global Head of Accessibility at Merck and MSD, where he established and led the company’s first Corporate Accessibility Office—a global, cross‑organizational team of more than 120 professionals driving enterprise‑wide digital accessibility, governance, and change management. A recognized leader in disability inclusion and equitable access, he has authored Merck’s company‑wide digital accessibility policy (WCAG 2.2 AA), built governance frameworks that scale across complex digital ecosystems, and shaped the organization’s global tone, voice, and training strategy for accessibility.
With over two decades of executive leadership across life sciences, financial services, marketing agencies, and nonprofit organizations, Stephen is known for operationalizing strategy, aligning senior leadership, and embedding accessibility into enterprise systems, procurement, and product development lifecycles. He is a prolific keynote speaker at major global conferences, a trusted advisor on disability inclusion, and a champion for building disability‑confident workforces.
Beyond his corporate leadership, Stephen is an accomplished cellist, conductor, and founder of multiple arts organizations, including Camerata Philadelphia and the Port City Music Festival. A CRC survivor (NED 2024) and 3X Ironman triathlete (2025), he brings a deep commitment to resilience, creativity, and the next generation of leaders.

With over two decades of executive leadership across life sciences, financial services, marketing agencies, and nonprofit organizations, Stephen is known for operationalizing strategy, aligning senior leadership, and embedding accessibility into enterprise systems, procurement, and product development lifecycles. He is a prolific keynote speaker at major global conferences, a trusted advisor on disability inclusion, and a champion for building disability‑confident workforces.

Portrait of Tim Glennon

Tim Glennon

Chief Revenue Officer

As a C-suite commercial and corporate executive with nearly 30 years in the life sciences industry, Tim has led organizations through complex growth phases-from early clinical development to full-scale commercialization and portfolio expansion. Over the course of his career, Tim has driven more than 15 successful product launches across Neurology (MS and Alzheimer’s), Cardiology, Women’s Health, Oncology, Infectious Diseases, Metabolic Disorders, Pain, Dermatology, and Rare Disease. His experience spans corporate strategy, sales and marketing leadership, business development, investor relations, market access, and both commercial and clinical operations.
Tim brings a broad enterprise lens to every engagement by aligning clinical development, regulatory strategy, and commercial planning to ensure companies not only bring meaningful therapies to patients, but also deliver sustainable value for shareholders.
Tim also serves as a fractional Chief Commercial Officer and strategic partner to small and mid-sized biopharma companies. Tim’s approach is pragmatic, accountable, and execution-focused, and he believes strategy only matters if it translates into action and results. In his own words, “At the end of the day, our responsibility is two-fold: “deliver innovative therapies to patients who need them, and create enduring value for the stakeholders who make that innovation.”

Portrait of Delphine Leveneur

Delphine Leveneur

Chief Inclusion Officer

Delphine brings over 18 years of experience in working with organizations and people with disabilities to drive positive change in society. Delphine Leveneur previous roles include being Chief Engagement Officer at Valuable 500 and being Global Accommodations Manager at Meta (previously Facebook). At Meta, where she spent 4.5 years, Delphine established their global workplace adjustment process (accommodations) outside the US, navigating the societal and cultural differences regarding disability across the world.
At Valuable 500, Delphine led 3 teams, focusing on the relationships with Valuable 500 Companies and Partners and Directory, and lead the team behind Generation Valuable, a reciprocate mentoring program
Prior to these roles, Delphine worked as a Senior Consultant at Business Disability Forum, aiding large organisations in their disability inclusion journey. She has also held roles supporting students with disabilities at universities in France and the UK.
Her postgraduate studies in France focused on Disability Inclusion and Accessibility and she remains passionate about progressing digital and physical accessibility cross our societies.
Originally from France with roots in Reunion Island, Delphine now calls the UK home, where she spent her free time completing a 2-year weaving diploma.